Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxia
The aim of the study was to investigate the involvement of bradykinin, cannabinoid and vanilloid (TRPV1 channel) receptors in the implementation of the infarct-limiting effect of chronic normobaric hypoxia (CNH).Materials and methods. The study was performed on male Wistar rats (n = 117) weighing 25...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2021-01-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/4161 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849773383914356736 |
|---|---|
| author | N. V. Naryzhnaya A. V. Mukhomedzyanov S. Yu. Tsibulnikov L. N. Maslov |
| author_facet | N. V. Naryzhnaya A. V. Mukhomedzyanov S. Yu. Tsibulnikov L. N. Maslov |
| author_sort | N. V. Naryzhnaya |
| collection | DOAJ |
| description | The aim of the study was to investigate the involvement of bradykinin, cannabinoid and vanilloid (TRPV1 channel) receptors in the implementation of the infarct-limiting effect of chronic normobaric hypoxia (CNH).Materials and methods. The study was performed on male Wistar rats (n = 117) weighing 250–300 g. Adaptation to CNH was modeled for 21 days at 12% pO2, 0.3% pCO2 and normal atmospheric pressure. A day after adaptation of rats to CNH coronary artery occlusion (45 min) and reperfusion (2 h) was performed. In the study the following compounds were used: selective cannabinoid CB1 receptor antagonist rimonabant (1 mg/kg), selective cannabinoid CB2 receptor antagonist AM630 (2.5 mg/kg), selective bradykinin B2 receptor antagonist HOE140 (50 μg/kg), and vanilloid receptor (TRPV1 channel) antagonist capsazepine (3 mg/kg). All antagonists were administered 15 min before coronary artery occlusion.Results. Adaptation to normobaric hypoxia promoted the formation of the pronounced infarct-limiting effect.The blockade of B2 receptor eliminated the infarct-limiting effect of CNH. Blockade of cannabinoid or vanilloidreceptors did not affect the infarct-limiting effect of CNH.Conclusion. The infarct-limiting effect of CNH depends on the activation of B2 receptor, and the adaptive increase in cardiac tolerance to ischemia/reperfusion does not depend on cannabinoid or vanilloid receptors. |
| format | Article |
| id | doaj-art-e4502de08cdf444783d4cf471d534cca |
| institution | DOAJ |
| issn | 1682-0363 1819-3684 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Siberian State Medical University (Tomsk) |
| record_format | Article |
| series | Бюллетень сибирской медицины |
| spelling | doaj-art-e4502de08cdf444783d4cf471d534cca2025-08-20T03:02:04ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842021-01-0119413814210.20538/1682-0363-2020-4-138-1422732Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxiaN. V. Naryzhnaya0A. V. Mukhomedzyanov1S. Yu. Tsibulnikov2L. N. Maslov3Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC), Russian Academy of ScienceCardiology Research Institute, Tomsk National Research Medical Center (TNRMC), Russian Academy of ScienceCardiology Research Institute, Tomsk National Research Medical Center (TNRMC), Russian Academy of ScienceCardiology Research Institute, Tomsk National Research Medical Center (TNRMC), Russian Academy of ScienceThe aim of the study was to investigate the involvement of bradykinin, cannabinoid and vanilloid (TRPV1 channel) receptors in the implementation of the infarct-limiting effect of chronic normobaric hypoxia (CNH).Materials and methods. The study was performed on male Wistar rats (n = 117) weighing 250–300 g. Adaptation to CNH was modeled for 21 days at 12% pO2, 0.3% pCO2 and normal atmospheric pressure. A day after adaptation of rats to CNH coronary artery occlusion (45 min) and reperfusion (2 h) was performed. In the study the following compounds were used: selective cannabinoid CB1 receptor antagonist rimonabant (1 mg/kg), selective cannabinoid CB2 receptor antagonist AM630 (2.5 mg/kg), selective bradykinin B2 receptor antagonist HOE140 (50 μg/kg), and vanilloid receptor (TRPV1 channel) antagonist capsazepine (3 mg/kg). All antagonists were administered 15 min before coronary artery occlusion.Results. Adaptation to normobaric hypoxia promoted the formation of the pronounced infarct-limiting effect.The blockade of B2 receptor eliminated the infarct-limiting effect of CNH. Blockade of cannabinoid or vanilloidreceptors did not affect the infarct-limiting effect of CNH.Conclusion. The infarct-limiting effect of CNH depends on the activation of B2 receptor, and the adaptive increase in cardiac tolerance to ischemia/reperfusion does not depend on cannabinoid or vanilloid receptors.https://bulletin.ssmu.ru/jour/article/view/4161myocardiumischemiareperfusionreceptorschronic hypoxia |
| spellingShingle | N. V. Naryzhnaya A. V. Mukhomedzyanov S. Yu. Tsibulnikov L. N. Maslov Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxia Бюллетень сибирской медицины myocardium ischemia reperfusion receptors chronic hypoxia |
| title | Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxia |
| title_full | Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxia |
| title_fullStr | Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxia |
| title_full_unstemmed | Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxia |
| title_short | Receptor mechanism of infarct-limiting effect of adaptation to normobaric hypoxia |
| title_sort | receptor mechanism of infarct limiting effect of adaptation to normobaric hypoxia |
| topic | myocardium ischemia reperfusion receptors chronic hypoxia |
| url | https://bulletin.ssmu.ru/jour/article/view/4161 |
| work_keys_str_mv | AT nvnaryzhnaya receptormechanismofinfarctlimitingeffectofadaptationtonormobarichypoxia AT avmukhomedzyanov receptormechanismofinfarctlimitingeffectofadaptationtonormobarichypoxia AT syutsibulnikov receptormechanismofinfarctlimitingeffectofadaptationtonormobarichypoxia AT lnmaslov receptormechanismofinfarctlimitingeffectofadaptationtonormobarichypoxia |